Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Equity (2022 - 2026)

HeartSciences (HSCS) has disclosed Return on Equity for 4 consecutive years, with 2.48% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 92.0% year-over-year to 2.48%, compared with a TTM value of 2.48% through Oct 2025, down 92.0%, and an annual FY2025 reading of 2.35%, down 59.0% over the prior year.
  • Return on Equity was 2.48% for Q4 2025 at HeartSciences, up from 5.27% in the prior quarter.
  • Across five years, Return on Equity topped out at 464.71% in Q2 2023 and bottomed at 16.44% in Q1 2023.
  • Average Return on Equity over 4 years is 31.52%, with a median of 1.56% recorded in 2024.
  • The sharpest move saw Return on Equity soared 46371bps in 2023, then plummeted -46555bps in 2024.
  • Year by year, Return on Equity stood at 3.36% in 2022, then surged by 267bps to 5.61% in 2023, then crashed by -128bps to 1.56% in 2024, then tumbled by -59bps to 2.48% in 2025.
  • Business Quant data shows Return on Equity for HSCS at 2.48% in Q4 2025, 5.27% in Q3 2025, and 8.89% in Q2 2025.